Related references
Note: Only part of the references are listed.Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
Timothy M. Nywening et al.
GUT (2018)
CXCL5 Facilitates Melanoma Cell-Neutrophil Interaction and Lymph Node Metastasis
Ana Soler-Cardona et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models
Nicole Salazar et al.
MOLECULAR THERAPY (2018)
CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis
Yang Zhang et al.
ONCOTARGETS AND THERAPY (2018)
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
Mana Taki et al.
NATURE COMMUNICATIONS (2018)
Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
Mieke Metzemaekers et al.
FRONTIERS IN IMMUNOLOGY (2018)
Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
Manja Idorn et al.
ONCOIMMUNOLOGY (2018)
Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
Yana G. Najjar et al.
CLINICAL CANCER RESEARCH (2017)
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
S. Lefort et al.
ONCOGENE (2017)
The Inflammatory CXC Chemokines, GROhigh, IP-10low, and MIGlow, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression
Ya Cao et al.
IMMUNOLOGICAL INVESTIGATIONS (2017)
Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages
Francesca Bellora et al.
JOURNAL OF IMMUNOLOGY (2017)
A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer
Ravi Salgia et al.
LUNG CANCER (2017)
A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis
Z. Xiang et al.
ONCOGENE (2017)
Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer
Jingkun Zhao et al.
ONCOTARGET (2017)
Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer
Larissa Kistner et al.
ONCOTARGET (2017)
CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients
C. Windmueller et al.
ONCOGENESIS (2017)
Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
Veronika Kremer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Interleukin-8 in cancer pathogenesis, treatment and follow-up
Carlos Alfaro et al.
CANCER TREATMENT REVIEWS (2017)
Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer
Anne F. Schott et al.
CLINICAL CANCER RESEARCH (2017)
Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment
Frederick S. Varn et al.
CANCER RESEARCH (2017)
CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma
Yusuke Sato et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
Zuqiang Liu et al.
ONCOIMMUNOLOGY (2016)
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
Holger Bronger et al.
BRITISH JOURNAL OF CANCER (2016)
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
Carlos Alfaro et al.
CLINICAL CANCER RESEARCH (2016)
CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation
Chang Xian Li et al.
JOURNAL OF HEPATOLOGY (2016)
Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors
Zinal S. Chheda et al.
JOURNAL OF IMMUNOLOGY (2016)
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
Babak Behnam Azad et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma
Timothy Chao et al.
CANCER IMMUNOLOGY RESEARCH (2016)
The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis
Shuo Zhang et al.
PLOS ONE (2016)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
M. E. Mikucki et al.
NATURE COMMUNICATIONS (2015)
CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity
Guiquan Zhu et al.
ONCOTARGET (2015)
STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis
Chanyu Yue et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Chemokine Receptor Expression on Normal Blood CD56+ NK-Cells Elucidates Cell Partners That Comigrate during the Innate and Adaptive Immune Responses and Identifies a Transitional NK-Cell Population
Margarida Lima et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment
Kar Wai Tan et al.
ONCOIMMUNOLOGY (2015)
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
Erik Wennerberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
Zhigang Zhang et al.
BMC CANCER (2014)
CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
Paolo Carrega et al.
JOURNAL OF IMMUNOLOGY (2014)
CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
Margaret Gil et al.
JOURNAL OF IMMUNOLOGY (2014)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
CXCR4, but not CXCR7, Discriminates Metastatic Behavior in Non-Small Cell Lung Cancer Cells
Young H. Choi et al.
MOLECULAR CANCER RESEARCH (2014)
Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis
Jingxun Wu et al.
TUMOR BIOLOGY (2014)
Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients
Talib Hassan Ali et al.
NATURE COMMUNICATIONS (2014)
The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases
Lianyu Chen et al.
SCIENTIFIC REPORTS (2014)
CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma
Pierre Saintigny et al.
CANCER RESEARCH (2013)
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
Dominic E. Sanford et al.
CLINICAL CANCER RESEARCH (2013)
Neuroblastoma-Derived TGF-β1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Chemokines in tumor progression and metastasis
Purvaba J. Sarvaiya et al.
ONCOTARGET (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer
Holger Bronger et al.
BREAST CANCER RESEARCH (2012)
CXCL12-CXCR4 chemokine signaling is essential for NK-cell development in adult mice
Mamiko Noda et al.
BLOOD (2011)
CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow
Giuseppe Sciume et al.
BLOOD (2011)
Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking
Katia Mayol et al.
BLOOD (2011)
CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells
S. Amatschek et al.
BRITISH JOURNAL OF CANCER (2011)
PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
Natasa Obermajer et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
Niels Halama et al.
CLINICAL CANCER RESEARCH (2011)
Foxp3(+)IL-17(+) T cells promote development of cancer-initiating cells in colorectal cancer
Shaobo Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
Benjamin Toh et al.
PLOS BIOLOGY (2011)
Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses
Weiyi Peng et al.
CLINICAL CANCER RESEARCH (2010)
CXCR7 Protein Is Not Expressed on Human or Mouse Leukocytes
Robert D. Berahovich et al.
JOURNAL OF IMMUNOLOGY (2010)
A Novel Mechanism of Soluble HLA-G Mediated Immune Modulation: Downregulation of T Cell Chemokine Receptor Expression and Impairment of Chemotaxis
Fabio Morandi et al.
PLOS ONE (2010)
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
B. Cambien et al.
BRITISH JOURNAL OF CANCER (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
Emmanuelle Pradelli et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
CCL3 and CXCL 12 regulate trafficking of mouse bone marrow NK cell subsets
Giovanni Bernardini et al.
BLOOD (2008)
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Marco Wendel et al.
CANCER RESEARCH (2008)
The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma
Tobias Klatte et al.
JOURNAL OF UROLOGY (2008)
Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro
Ji-Kun Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Down-modulation of CXCR3 surface expression and function in CD8+ T cells from cutaneous T cell lymphoma patients
Dorian Winter et al.
JOURNAL OF IMMUNOLOGY (2007)
Immune-mediated modulation of breast cancer growth and metastasis by the chemokine mig (CXCL9) in a murine model
Tonya C. Walser et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches
Tatsuki Sugiyama et al.
IMMUNITY (2006)
CD4+ CXCR4high CD69+ T cells accumulate in lung adenocarcinoma
Ori Wald et al.
JOURNAL OF IMMUNOLOGY (2006)
CXCR4 physically associates with the T cell receptor to signal in T cells
Ashok Kumar et al.
IMMUNITY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth
YS Sun et al.
CANCER GENE THERAPY (2005)
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells
A Ottaiano et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma
S Scala et al.
CLINICAL CANCER RESEARCH (2005)
Furin is a chemokine-modifying enzyme -: In vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity
PJ Hensbergen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals
LH Zou et al.
CANCER RESEARCH (2004)
Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo
YX Sun et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts
AL Feldman et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties
P Proost et al.
BLOOD (2001)
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
WP Zou et al.
NATURE MEDICINE (2001)
Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family
AM Lambeir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Share Paper
